Literature DB >> 24588361

Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis.

V Lilleby1, J Haydon, H Sanner, B K Krossness, G Ringstad, B Flatø.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24588361     DOI: 10.3109/03009742.2013.863968

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  6 in total

Review 1.  Macrophage activation syndrome in juvenile dermatomyositis: a systematic review.

Authors:  Dimitri Poddighe; Kaisar Dauyey
Journal:  Rheumatol Int       Date:  2019-09-16       Impact factor: 2.631

2.  Macrophage activation syndrome as a complication of dermatomyositis: A case report.

Authors:  Ding-Xian Zhu; Jian-Jun Qiao; Hong Fang
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

3.  Case Report: Macrophage Activation Syndrome and Widespread Neuroimaging Abnormality in Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Nana Shi; Xiangying Wang; Lixia Zou; Xinghui Yang; Qian Ma; Meiping Lu
Journal:  Front Pediatr       Date:  2021-12-14       Impact factor: 3.418

4.  The unusual suspects: a curious case of acute kidney injury-Answers.

Authors:  Jessica L Stahl; Joe C Rutledge; Roberto Gordillo
Journal:  Pediatr Nephrol       Date:  2019-01-16       Impact factor: 3.714

5.  Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels.

Authors:  Hiroyuki Wakiguchi; Shunji Hasegawa; Reiji Hirano; Hidenobu Kaneyasu; Midori Wakabayashi-Takahara; Shouichi Ohga
Journal:  Pediatr Rheumatol Online J       Date:  2015-11-18       Impact factor: 3.054

Review 6.  The off-label use of anakinra in pediatric systemic autoinflammatory diseases.

Authors:  Valerio Maniscalco; Sarah Abu-Rumeileh; Maria Vincenza Mastrolia; Edoardo Marrani; Ilaria Maccora; Ilaria Pagnini; Gabriele Simonini
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-10-16       Impact factor: 5.346

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.